Human papillomavirus (HPV) DNA test is a reliable detection of high-risk DNA types including types 16, 18, and 45. According to the World Health Organization (WHO), DNA-based testing is more effective and more efficient than cytology-based tests (or pap smear) as they are less prone to quality problems. It is in fact recommended as the primary screening method by the WHO.
“These deaths can be avoided. Thanks to screening, and notably using the HPV DNA-based tests, cervical cancer can either be prevented or detected at early stages and cured,” said Dr. Marilys Corbex, Senior Technical Officer on noncommunicable diseases, WHO Europe.
HPV is an invisible enemy
Human papillomavirus is a threat to many women. Worldwide, it causes about 70% of cervical cancer cases. In the Philippines, it is the second most common cancer among women aged 14 to 44, with 7,897 diagnosed and 4,042 deaths from cervical cancer annually.
It is an invisible enemy women have to be wary of. Human papillomavirus does not often present visible symptoms. When symptoms appear, these are manifested as genital warts which can only be detected through thorough physical examination by the OB-GYN.
Early detection can save lives
By encouraging women to take an HPV-DNA test, those identified to be positive can be given the proper management and treatment in a timely manner.
Help women get the best treatment they deserve.
References:
- World Health Organization. WHO recommends DNA testing as a first-choice screening method for cervical cancer prevention. 11 September 2021.
- WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
- Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, Muñoz J, Bosch FX, ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human and Related Diseases in Philippines. Summary Report 10 March 2023. [Date Accessed]